{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:21:16Z","timestamp":1776331276191,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The benefit of routine lymphadenectomy (LD) in improving outcomes for patients with primary intrahepatic cholangiocarcinoma (ICC) undergoing curative hepatectomy remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This study enrolled 269 consecutive patients who underwent liver resection for primary ICC from January 2009 to July 2020 in West China Hospital. The association of the nodal status with disease-free survival (DFS) and overall survival (OS) was analyzed using the Cox proportional hazards model and 1:1 propensity score matching (PSM) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-five (27.9%) patients underwent curative liver resection combined with LD (LD+ group), while 194 (72.1%) patients received curative liver resection without LD (LD- group and Nx group). Among the LD+ group, metastatic disease was present in 36 patients (48%, N1 group) and absent in 39 patients (N0 group). During the follow-up period, 116 patients (43.1%) experienced tumor recurrence and 101 patients (37.5%) died due to recurrence. Multivariate analysis revealed that lymph node metastasis (N1, HR 3.682, 95% CI 1.949\u20136.957,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) was associated with worse OS, while LD+ status (HR 0.504, 95% CI 0.298\u20130.853,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011) was associated with improved OS. Adjuvant therapy was a protective factor for both DFS (HR 0.602, 95% CI, 0.447\u20130.810,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) and OS (HR 0.683, 95% CI 0.484\u20130.963,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.030). After 1:1 PSM, the LD+ patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200974) displayed similar 1-, 3- and 5-year DFS rates (40.0, 7.9 and 7.9% vs. 29.0, 13.7 and 13.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.741) and OS rates (56.0, 26.6 and 22.2% vs. 58.9, 25.6, and 16.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.644) to the LD- patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200974). Additionally, among the 75 LD+ patients, 48 patients underwent hepatic hilar lymphadenectomy (HHL), and 27 patients underwent extended hepatic hilar lymphadenectomy (EHL). Both DFS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.504) and OS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.215) were similar between the HHL and EHL groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Routine LD and adjuvant therapy may contribute to improved OS according to the crude analysis. LD could provide accurate staging without excessive risk and guide adjuvant therapy based on the tumor stage, potentially resulting in better survival. These results suggest that a routine LD should be considered during curative hepatectomy for ICC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-023-02255-5","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T05:02:32Z","timestamp":1701320552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Shan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Sheng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"2255_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84\u201396.","journal-title":"Ann Surg."},{"key":"2255_CR2","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1245\/s10434-021-09671-y","volume":"28","author":"ZV Fong","year":"2021","unstructured":"Fong ZV, Brownlee SA, Qadan M, Tanabe KK. The clinical Management of Cholangiocarcinoma in the United States and Europe: a comprehensive and evidence-based comparison of guidelines. Ann Surg Oncol. 2021;28:2660\u201374.","journal-title":"Ann Surg Oncol."},{"key":"2255_CR3","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC de Jong","year":"2011","unstructured":"de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140\u20135.","journal-title":"J Clin Oncol."},{"key":"2255_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol."},{"key":"2255_CR5","doi-asserted-by":"publisher","first-page":"e1187","DOI":"10.1097\/SLA.0000000000003788","volume":"274","author":"XF Zhang","year":"2021","unstructured":"Zhang XF, Xue F, Dong DH, Weiss M, Popescu I, Marques HP, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic Cholangiocarcinoma impact prognosis. Ann Surg. 2021;274:e1187\u201395.","journal-title":"Ann Surg."},{"issue":"3","key":"2255_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1245\/s10434-022-12797-2","volume":"30","author":"XF Zhang","year":"2023","unstructured":"Zhang XF, Xue F, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Cauchy F, Martel G, Koerkamp BG, Itaru E, Lv Y, Pawlik TM. Lymph node examination and patterns of nodal metastasis among patients with left- versus right-sided intrahepatic Cholangiocarcinoma after major curative-intent resection. Ann Surg Oncol. 2023;30(3):1424\u201333.","journal-title":"Ann Surg Oncol."},{"key":"2255_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.surg.2008.11.010","volume":"145","author":"K Shimada","year":"2009","unstructured":"Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, et al. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009;145:411\u20136.","journal-title":"Surgery."},{"key":"2255_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jhep.2022.10.021","volume":"78","author":"C Sposito","year":"2023","unstructured":"Sposito C, Ratti F, Cucchetti A, Ardito F, Ruzzenente A, Di Sandro S, et al. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol. 2023;78:356\u201363.","journal-title":"J Hepatol."},{"key":"2255_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00535-015-1071-2","volume":"50","author":"Y Morine","year":"2015","unstructured":"Morine Y, Shimada M. The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol. 2015;50:913\u201327.","journal-title":"J Gastroenterol."},{"key":"2255_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jso.24720","volume":"116","author":"Y Kim","year":"2017","unstructured":"Kim Y, Moris DP, Zhang XF, Bagante F, Spolverato G, Schmidt C, et al. Evaluation of the 8th edition American joint commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol. 2017;116:643\u201350.","journal-title":"J Surg Oncol."},{"key":"2255_CR11","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1245\/s10434-014-4239-8","volume":"22","author":"T Adachi","year":"2015","unstructured":"Adachi T, Eguchi S, Beppu T, Ueno S, Shiraishi M, Okuda K, et al. Prognostic impact of preoperative lymph node enlargement in intrahepatic cholangiocarcinoma: a multi-institutional study by the kyushu study group of liver surgery. Ann Surg Oncol. 2015;22:2269\u201378.","journal-title":"Ann Surg Oncol."},{"key":"2255_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1365-182X(17)30755-4","volume":"2","author":"Terminology Committee of the IHPBA","year":"2000","unstructured":"Terminology Committee of the IHPBA. Terminology of liver anatomy and resections. HPB (Oxford). 2000;2:333\u20139.","journal-title":"HPB (Oxford)."},{"key":"2255_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"2255_CR14","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RJ D'Agostino","year":"1998","unstructured":"D'Agostino RJ. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265\u201381.","journal-title":"Stat Med."},{"key":"2255_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1046\/j.1365-2168.2002.02268.x","volume":"89","author":"M Ohtsuka","year":"2002","unstructured":"Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525\u201331.","journal-title":"Br J Surg."},{"key":"2255_CR16","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1245\/s10434-019-07483-9","volume":"26","author":"K Sahara","year":"2019","unstructured":"Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, et al. Therapeutic index associated with lymphadenectomy among patients with intrahepatic Cholangiocarcinoma: which patients benefit the Most from nodal evaluation? Ann Surg Oncol. 2019;26:2959\u201368.","journal-title":"Ann Surg Oncol."},{"key":"2255_CR17","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1097\/SLA.0000000000003478","volume":"274","author":"XF Zhang","year":"2021","unstructured":"Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, et al. New nodal staging for primary pancreatic neuroendocrine tumors: a multi-institutional and National Data Analysis. Ann Surg. 2021;274:e28\u201335.","journal-title":"Ann Surg."},{"key":"2255_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jso.23715","volume":"110","author":"AL Gleisner","year":"2014","unstructured":"Gleisner AL, Spolverato G, Ejaz A, Pawlik TM. Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer. J Surg Oncol. 2014;110:858\u201363.","journal-title":"J Surg Oncol."},{"key":"2255_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jss.2020.08.041","volume":"258","author":"FB Maegawa","year":"2021","unstructured":"Maegawa FB, Ashouri Y, Hamidi M, Hsu CH, Riall TS. Gallbladder Cancer surgery in the United States: lymphadenectomy trends and impact on survival. J Surg Res. 2021;258:54\u201363.","journal-title":"J Surg Res."},{"key":"2255_CR20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jamcollsurg.2012.08.001","volume":"215","author":"MN Mavros","year":"2012","unstructured":"Mavros MN, Mayo SC, Hyder O, Pawlik TM. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg. 2012;215:820\u201330.","journal-title":"J Am Coll Surg."},{"issue":"4","key":"2255_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1245\/s10434-022-13044-4","volume":"30","author":"Z Moazzam","year":"2023","unstructured":"Moazzam Z, Alaimo L, Endo Y, Lima HA, Pawlik TM. Predictors, patterns, and impact of adequate lymphadenectomy in intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2023;30(4):1966\u201377.","journal-title":"Ann Surg Oncol."},{"key":"2255_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11605-017-3652-2","volume":"22","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Chen Q, Kimbrough CW, Beal EW, Lv Y, Chakedis J, et al. Lymphadenectomy for intrahepatic Cholangiocarcinoma: has nodal evaluation been increasingly adopted by surgeons over time?A National Database Analysis. J Gastrointest Surg. 2018;22:668\u201375.","journal-title":"J Gastrointest Surg."},{"key":"2255_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/bjs.10827","volume":"105","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Chakedis J, Bagante F, Chen Q, Beal EW, Lv Y, et al. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. Br J Surg. 2018;105:857\u201366.","journal-title":"Br J Surg."},{"key":"2255_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1245\/s10434-008-0180-z","volume":"16","author":"H Nathan","year":"2009","unstructured":"Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16:14\u201322.","journal-title":"Ann Surg Oncol."},{"key":"2255_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jamcollsurg.2015.09.012","volume":"221","author":"F Bagante","year":"2015","unstructured":"Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, et al. Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg. 2015;221:1031\u201340.","journal-title":"J Am Coll Surg."},{"key":"2255_CR26","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","volume":"16","author":"SB Choi","year":"2009","unstructured":"Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol. 2009;16:3048\u201356.","journal-title":"Ann Surg Oncol."}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-023-02255-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-023-02255-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-023-02255-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T05:06:35Z","timestamp":1701320795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-023-02255-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2255"],"URL":"https:\/\/doi.org\/10.1186\/s12893-023-02255-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2245109\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Institutional Review Board of the West China Hospital of Sichuan University, and was performed in accordance with the ethical principles of the Declaration of Helsinki. And written informed consents were obtained from all of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}